FDA — authorised 29 July 1969
- Marketing authorisation holder: SANDOZ
- Status: approved
🇺🇸 Aristospan in United States
FDA authorised Aristospan on 29 July 1969
Marketing authorisations
FDA — authorised 29 July 1969
- Application: NDA016466
- Marketing authorisation holder: ETHYPHARM
- Local brand name: ARISTOSPAN
- Indication: INJECTABLE — INJECTION
- Status: approved
Aristospan in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Aristospan approved in United States?
Yes. FDA authorised it on 29 July 1969; FDA authorised it on 29 July 1969.
Who is the marketing authorisation holder for Aristospan in United States?
SANDOZ holds the US marketing authorisation.